Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Purchase of 220,070 ALMS shares, $2.46M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | ALUMIS INC. (ALMS) | Purchase | 220,070 | $2.46M |
| Jul 2, 2026 | ALUMIS INC. (ALMS) | Grant/Award | 3,553 | n/a |
| Jun 29, 2026 | vTv Therapeutics Inc. (VTVT) | Grant/Award | 6,000 | $210.5K |
| Jun 8, 2026 | Scholar Rock Holding Corp (SRRK) | Grant/Award | 6,839 | n/a |
| Jun 4, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 9,000 | n/a |
| May 22, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Purchase | 244,300 | $1.18M |
| Feb 21, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 6,200 | n/a |
| Feb 18, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Purchase | 479,847 | $5.00M |
| Jan 13, 2026 | ALUMIS INC. (ALMS) | Purchase | 588,235 | $10.00M |
| Dec 22, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 1,500,000 | $15.00M |